Abstract
ABSTRACT Congenital adrenal cortical hyperplasia has been produced in the offspring of pregnant rats treated with metyrapone, an inhibitor of 11β-steroid hydroxylase. Female offspring also have clitoral hypertrophy, and activity of glucose-6-phosphate dehydrogenase is increased in maternal and fetal adrenal glands by this agent. These effects are reduced by corticosterone. Basal corticosterone production and the increased corticosterone production due to the addition of substrates of 11β-steroid hydroxylase in quartered adrenal glands are markedly reduced in mature females treated with metyrapone. These experiments have shown that an inhibitor of 11β-steroid hydroxylase produces the same type of congenital adrenal cortical hyperplasia and clitoral hypertrophy which occur spontaneously in the hypertensive form of congenital adrenal hyperplasia due to a genetic deficiency of this enzyme.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Journal of clinical endocrinology and metabolism
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
